Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Sees Large Increase in Short Interest

Key Points

• Xtant Medical's short interest rose to 23,175 shares as of March 13, a 28.6% increase from Feb. 26, though it still represents roughly 0.0% of outstanding shares and a days‑to‑cover of 0.2.
• The stock traded around $0.55 with a market cap of $77.4M, a PE of 55.4, 50‑/200‑day SMAs of $0.60/$0.67, and a 52‑week range of $0.34–$0.95.
• Craig Hallum reaffirmed a Buy and the consensus rating is Buy with an average price target of $1.50, while about 69.33% of shares are owned by hedge funds and other institutions after several recent small stakes.

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT - Get Free Report) saw a significant increase in short interest during the month of March. As of March 13th, there was short interest totaling 23,175 shares, an increase of 28.6% from the February 26th total of 18,020 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily trading volume, of 120,867 shares, the days-to-cover ratio is presently 0.2 days.

Xtant Medical Stock Performance

NYSEAMERICAN:XTNT opened at $0.55 on Monday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.06 and a current ratio of 2.21. The stock has a 50-day simple moving average of $0.60 and a two-hundred day simple moving average of $0.67. The firm has a market capitalization of $77.42 million, a PE ratio of 55.36 and a beta of -0.30. Xtant Medical has a 52-week low of $0.34 and a 52-week high of $0.95.

Wall Street Analyst Weigh In

Separately, Craig Hallum reaffirmed a "buy" rating on shares of Xtant Medical in a report on Wednesday, March 18th. Two analysts have rated the stock with a Buy rating, According to MarketBeat, the stock has a consensus rating of "Buy" and an average price target of $1.50.

Institutional Investors Weigh In On Xtant Medical

Several hedge funds and other institutional investors have recently added to or reduced their stakes in XTNT. Jane Street Group LLC bought a new stake in Xtant Medical during the 2nd quarter worth approximately $26,000. Tradition Wealth Management LLC bought a new position in shares of Xtant Medical in the fourth quarter worth approximately $79,000. Wiregrass Investment Management LLC purchased a new stake in shares of Xtant Medical in the fourth quarter worth $81,000. Mink Brook Asset Management LLC increased its stake in shares of Xtant Medical by 125.8% in the second quarter. Mink Brook Asset Management LLC now owns 109,466 shares of the medical device company's stock worth $81,000 after purchasing an additional 60,997 shares in the last quarter. Finally, Nano Cap New Millennium Growth Fund L P bought a new stake in shares of Xtant Medical during the 4th quarter valued at $220,000. 69.33% of the stock is owned by hedge funds and other institutional investors.

Xtant Medical Company Profile

Xtant Medical, Inc is a medical technology company focused on the development, manufacturing and distribution of bone graft, spine biologics and related implantable medical devices. The company's product portfolio is designed to address critical needs in spinal fusion, orthopedics and trauma surgery by providing a range of solutions that promote bone growth, structural support and patient recovery.

The company's offerings include an array of bone graft substitutes – such as demineralized bone matrix putties and fibers – interbody fusion devices, spinal fixation systems and biologic agents.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.